Microbot Medical Inc. issued a statement supporting the American Medical Association’s newly adopted policy to expand protections for healthcare professionals from occupational ionizing radiation exposure. The company said the guidance highlights the need for technologies such as its LIBERTY Endovascular Robotic System, which it says allows clinicians to operate farther from radiation sources and reduce reliance on heavy protective gear. Microbot cited results from its ACCESS-PVI study showing a 92% relative reduction in radiation exposure when using LIBERTY, and linked radiation concerns to staffing shortages and barriers for women in endovascular specialties.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603040830PRIMZONEFULLFEED9665346) on March 04, 2026, and is solely responsible for the information contained therein.
Comments